These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25335776)

  • 1. Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study.
    Fusar-Poli P; Frascarelli M; Valmaggia L; Byrne M; Stahl D; Rocchetti M; Codjoe L; Weinberg L; Tognin S; Xenaki L; McGuire P
    Psychol Med; 2015 Apr; 45(6):1327-39. PubMed ID: 25335776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for clinical interventions in prodromal psychosis. Are such interventions safe?
    Agius M; Butler S
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S28-35. PubMed ID: 22945183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis.
    Fusar-Poli P; Byrne M; Badger S; Valmaggia LR; McGuire PK
    Eur Psychiatry; 2013 Jun; 28(5):315-26. PubMed ID: 23137782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programma 2000: celebrating 10 years of activity of an Italian pilot programme on early intervention in psychosis.
    Cocchi A; Meneghelli A; Preti A
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1003-12. PubMed ID: 19016088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
    Bechdolf A; Müller H; Stützer H; Wagner M; Maier W; Lautenschlager M; Heinz A; de Millas W; Janssen B; Gaebel W; Michel TM; Schneider F; Lambert M; Naber D; Brüne M; Krüger-Özgürdal S; Wobrock T; Riedel M; Klosterkötter J;
    Schizophr Bull; 2011 Sep; 37 Suppl 2(Suppl 2):S111-21. PubMed ID: 21860040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.
    McGorry PD; Nelson B; Phillips LJ; Yuen HP; Francey SM; Thampi A; Berger GE; Amminger GP; Simmons MB; Kelly D; Dip G; Thompson AD; Yung AR
    J Clin Psychiatry; 2013 Apr; 74(4):349-56. PubMed ID: 23218022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescents and young adults at ultrahigh risk of psychosis: detection, prediction and treatment. A review of current knowledge.
    Mees L; Zdanowicz N; Reynaert C; Jacques D
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S118-22. PubMed ID: 21894117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS).
    Pyle M; Broome MR; Joyce E; MacLennan G; Norrie J; Freeman D; Fowler D; Haddad PM; Shiers D; Hollis C; Smith J; Liew A; Byrne RE; French P; Peters S; Hudson J; Davies L; Emsley R; Yung A; Birchwood M; Longden E; Morrison AP
    Trials; 2019 Jul; 20(1):395. PubMed ID: 31272477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial.
    Hjorthøj CR; Fohlmann A; Larsen AM; Gluud C; Arendt M; Nordentoft M
    Psychol Med; 2013 Jul; 43(7):1499-510. PubMed ID: 23040144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project.
    Jackson HJ; McGorry PD; Killackey E; Bendall S; Allott K; Dudgeon P; Gleeson J; Johnson T; Harrigan S
    Psychol Med; 2008 May; 38(5):725-35. PubMed ID: 18005494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial.
    Stain HJ; Bucci S; Baker AL; Carr V; Emsley R; Halpin S; Lewin T; Schall U; Clarke V; Crittenden K; Startup M
    Schizophr Res; 2016 Oct; 176(2-3):212-219. PubMed ID: 27554197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence map of interventions across premorbid, ultra-high risk and first episode phases of psychosis.
    Liu P; Parker AG; Hetrick SE; Callahan P; de Silva S; Purcell R
    Schizophr Res; 2010 Oct; 123(1):37-44. PubMed ID: 20558043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis.
    Addington J; Epstein I; Liu L; French P; Boydell KM; Zipursky RB
    Schizophr Res; 2011 Jan; 125(1):54-61. PubMed ID: 21074974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A naturalistic longitudinal study of at-risk mental state with a 2.4 year follow-up at a specialized clinic setting in Japan.
    Katsura M; Ohmuro N; Obara C; Kikuchi T; Ito F; Miyakoshi T; Matsuoka H; Matsumoto K
    Schizophr Res; 2014 Sep; 158(1-3):32-8. PubMed ID: 25034763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample.
    Walker EF; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Heinssen R
    Schizophr Res; 2009 Nov; 115(1):50-7. PubMed ID: 19709859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group cognitive behavioural therapy for first episode psychosis: who's referred, who attends and who completes it?
    Fanning F; Foley S; Lawlor E; McWilliams S; Jackson D; Renwick L; Sutton M; Turner N; Kinsella A; Trimble T; O'Callaghan E
    Early Interv Psychiatry; 2012 Nov; 6(4):432-41. PubMed ID: 22240156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.